ELICERA THERAPEUTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 SEK | +8.47% |
|
+31.69% | -71.93% |
| 05-29 | Elicera Therapeutics Set to Begin First Clinical CAR T-Cell study CARMA | CI |
| 05-27 | Elicera Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.26M | - | - | - | - | - | |
| 765B | ||||||
| 632B | ||||||
| 354B | ||||||
| 331B | ||||||
| 299B |
